A Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of a Single Oral Dose of 5-HT1A Antagonist GSK958108 on Ejaculation Latency Time in Male Patients Suffering From Premature Ejaculation

早泄 敌手 双盲 延迟(音频) 安慰剂 医学 麻醉 心理学 计算机科学 内科学 电信 受体 替代医学 病理 精神分析
作者
Filippo Migliorini,Alessandro Tafuri,P. Bettica,Luigi Ziviani,Jesper Lund,Italo Poggesi,Anna Marcer,Giovanni Cacciamani,María Fernanda Lorenzo-Gómez,Antonio Benito Porcaro,Alessandro Antonelli,Stefano Milleri
出处
期刊:The Journal of Sexual Medicine [Elsevier BV]
卷期号:18 (1): 63-71 被引量:10
标识
DOI:10.1016/j.jsxm.2020.09.012
摘要

BACKGROUND: Premature ejaculation (PE) is a common male neurobiological sexual disorder, related to a disturbance in central serotonin (5-hydroxytryptamine or 5-HT) neurotransmission. AIM: receptor antagonist GSK958108 on ejaculation latency time (ELT) in male subjects suffering from PE. METHODS: A total of 35 male subjects were enrolled in a Phase 1 double-blind, placebo-controlled, parallel group masturbation-model study. All subjects completed the study. No subject was withdrawn from the study. There were no major protocol deviations reported during the study. OUTCOMES: receptor antagonist GSK958108 on ELT as measured in the masturbation model; additionally, we investigated drug's safety and tolerability. RESULTS: In the 3 mg GSK958108 treatment group, the ELT was estimated to be 16% longer (1.542 vs 1.328, 95% CI: -16% to +61%) than if the subjects had taken placebo. In the 7 mg GSK958108 treatment group, the ELT was estimated to be 77% longer (2.346 vs 1.328, 95% CI: +28% to +144%) than in the placebo group. The systemic exposure to GSK958108 increased with dosage between 3 mg and 7 mg. A significant trend toward an increase of ELT was observed with increasing plasma concentrations of GSK958108. A total of 4 patients all treated with 7 mg dose experienced minor drug related adverse events (5 adverse events in 4 patients): somnolence (n = 3), headache (n = 1), tinnitus (n = 1). CLINICAL IMPLICATIONS: receptor antagonist GSK958108 was tested in 3 mg and 7 mg doses for PE treatment in humans. It was shown that GSK958108 significantly delayed ejaculation showing a new and safe alternative in PE treatment. STRENGTHS & LIMITATIONS: receptor antagonist in the PE treatment. However, the use of masturbation model and the small population are the main limitations of this investigation. CONCLUSION: receptor antagonist GSK958108 3 mg per day and 7 mg per day was found to be well-tolerated, safe and effective for the treatment of PE subjects and demonstrated a strong association between 5HT1A receptors and ejaculation control in humans (NCT00861484). Migliorini F, Tafuri A, Bettica P, et al. A Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of a Single Oral Dose of 5-HT1A Antagonist GSK958108 on Ejaculation Latency Time in Male Patients Suffering From Premature Ejaculation. J Sex Med 2021;18:63-71.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
活雷锋应助科研狗采纳,获得10
刚刚
木木发布了新的文献求助10
2秒前
3秒前
脑洞疼应助Suyi采纳,获得10
4秒前
6秒前
CipherSage应助llllllllxxy采纳,获得10
7秒前
8秒前
8秒前
wang050604发布了新的文献求助10
9秒前
整个好活给My_magnum_opus的求助进行了留言
9秒前
9秒前
10秒前
11秒前
001发布了新的文献求助10
13秒前
Mountain发布了新的文献求助10
13秒前
JIN0发布了新的文献求助30
13秒前
中恐完成签到,获得积分0
14秒前
15秒前
16秒前
16秒前
Suyi发布了新的文献求助10
16秒前
17秒前
日月完成签到 ,获得积分10
18秒前
19秒前
My_magnum_opus发布了新的文献求助150
19秒前
洁净的谷兰完成签到,获得积分10
20秒前
黄丽华发布了新的文献求助10
20秒前
20秒前
文静曼香完成签到 ,获得积分10
20秒前
21秒前
Hello应助小兰采纳,获得10
22秒前
momo妈咪发布了新的文献求助10
23秒前
24秒前
24秒前
搜集达人应助廖嘉俊采纳,获得10
24秒前
科研通AI6.2应助鳗鱼颖采纳,获得10
24秒前
molihuakai应助鳗鱼颖采纳,获得10
24秒前
科研通AI6.2应助鳗鱼颖采纳,获得10
25秒前
搜集达人应助Yzw采纳,获得10
25秒前
李健应助鳗鱼颖采纳,获得10
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Effects of Two Weeks of Red Light Therapy on Choroidal Thickness and Axial Length in Young Adults 700
Positive Art Therapy Theory and Practice 600
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Key mechanistic insights into the intramolecular C-H bond amination and double bond aziridination in sulfamate esters catalyzed by dirhodium tetracarboxylate complexes 500
The Neuroscience of Language 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7671797
求助须知:如何正确求助?哪些是违规求助? 9238985
关于积分的说明 19898293
捐赠科研通 7241372
什么是DOI,文献DOI怎么找? 3285173
关于科研通互助平台的介绍 2443400
邀请新用户注册赠送积分活动 2287342